Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
bluebird bio, Inc. | Chief Financial Officer | Common Stock | 45.5K | $65K | $1.43 | Dec 6, 2023 | Direct |
bluebird bio, Inc. | Chief Financial Officer | Stock Option (right to buy) | 199K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EGRX | EAGLE PHARMACEUTICALS, INC. | Nov 11, 2024 | 0 | $0 | 3 | Nov 19, 2024 | Chief Financial Officer |
BLUE | bluebird bio, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 5, 2024 | Chief Financial Officer |
BLUE | bluebird bio, Inc. | Dec 6, 2023 | 1 | -$20.4K | 4 | Dec 8, 2023 | Chief Financial Officer |
BLUE | bluebird bio, Inc. | Dec 1, 2022 | 2 | $0 | 4 | Dec 5, 2022 | Chief Financial Officer |
BLUE | bluebird bio, Inc. | Nov 7, 2022 | 0 | $0 | 3 | Nov 7, 2022 | Chief Financial Officer |